AMTM vs RARE · rev $14.39B vs rev $350.0M
Amentum Holdings Inc. (AMTM) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Amentum Holdings Inc. (AMTM) is a specialty business services company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported AMTM revenue for 2025-10-03 was $14.39B. Net income was $66.0M. Revenue was up 71.6% from 2024-09-27 to 2025-10-03. AMTM currently screens at market cap $4.87B.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
AMTM currently screens at market cap $4.87B. RARE currently screens at market cap $2.79B.
Not investment advice. Open the AMTM and RARE stock pages for the full models.
Not investment advice.